Table 2.
ADAMTS-1 expression (median value) according to clinicopathological features and biomolecular markers in primary breast tumors
| Variable | Categories | n | ADAMTS-1 expression | p value |
|---|---|---|---|---|
| Age (years old) |
< 50 |
22 |
0.350 |
MW: 0.534 |
| |
≥ 50 |
38 |
0.475 |
|
| Stage (TNM) |
Stage I |
2 |
0.225 |
KW: 0.006 |
| |
Stage II |
25 |
0.250 |
|
| |
Stage III |
26 |
0.625 |
|
| |
Stage IV |
7 |
1.100 |
|
| Tumor size (cm) |
< 4.0 |
21 |
0.350 |
MW:0.950 |
| |
≥ 4.0 |
39 |
0.400 |
|
| Lymph node metastasis |
No |
20 |
0.450 |
MW: 0.712 |
| |
Yes |
40 |
0.350 |
|
| Estrogen receptor |
Negative |
27 |
0.350 |
MW: 0.291 |
| |
Positive |
33 |
0.600 |
|
| Progesterone receptor |
Negative |
33 |
0.550 |
MW: 0.731 |
| Positive | 26 | 0.350 |
KW: Kruskal Wallis test.
MW: Mann Whitney test.